5 results
Selected Clinical Trials of SGLT2 inhibitors in CVD and CKD
EMPA-REG OUTCOME - Empagliflozin lowered CV events
in HF and CKD. ... in HF and CKD. ... in HFrEF on GDMT ... visualabstract #table ... #CVD #CKD
Guideline-Directed Medical Therapy (GDMT) in HFrEF and CKD

 • Class I pillars of HFrEF GDMT across
Medical Therapy (GDMT ... ) in HFrEF and CKD ... diuretics, MRA, SGLT2i ... #CKD #HFrEF #management ... #pharmacology #cardiology
Stages in the development of HF and recommended therapy by stage. ACEI indicates angiotensin-converting enzyme inhibitor;
development of HF ... angiotensin-receptor blocker; CAD ... ejection fraction; GDMT ... #CHF #Congestive ... Algorithm #Management #Cardiology
Chest Pain - Differential Diagnosis Framework

Cardiovascular Causes of Chest Pain:
 • Myocardium:
	- Myocarditis
	- CAD/ACS
	- Valvulopathy
	- Myopericarditis
Myocarditis - CAD ... • Alveoli: - CHF ... - Pneumonia ... Diagnosis #Causes #Cardiology
Beta Blockers - Pharmacology Comparison Table
Metoprolol:
 • Receptors: β1
 • Indications: Rate control of a-fib/a-flutter, Suppression
Pharmacology Comparison Table ... indicated in pt w/o CAD ... /HF but limited ... Pharmacology #Comparison #Table ... #Receptors #cardiology